Orchestra BioMed (OBIO) Misses Q1 EPS by 49c

Orchestra BioMed (NASDAQ: OBIO) reported Q1 EPS of ($0.49). Revenue for the quarter came in at $900 thousand.

For earnings history and earnings-related data on Orchestra BioMed (OBIO) click here.

You May Also Be Interested In

• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
• McCormick & Company (MKC) Reiterated at Hold by Stifel After 'Strong Than Expected' Q2
• SanDisk stock target lifted by Citi on continued demand strength